Szemészet, 2016 (153. évfolyam, 1-4. szám)
2016-06-01 / 2. szám
Osmolarity measurement in dry eye disease 11. Khanal S, Millar TJ. Barriers to clinical uptake of tear osmolarity measurements. Br J Ophthalmol 2012; 96: 341-4. 12. Lemp MA, Baudouin 0, Baum J, et a I. The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international Dry Eye Workshop (2007). Ocul Surf 2007; 5: 75-92. 13. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011; 151: 792-798. 14. Li DQ, Chen Z, Song XJ, et al. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sei 2004; 45: 4302-11. 15. Liu H, Begley C, Chen M, et al. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sei 2009; 50: 3671-9. 16. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and МАРК pathways. Cornea 2007; 26: 452-60. 17. Messmer EM, Bulgen M, Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol 2010; 45: 129-38. 18. Módis L, Szalai E, Szekanecz Z, et al. A könny ozmolaritásának vizsgálata Sjögren-szindrómában TearLab ozmométerrel Szemészet 2010; 147: 138-142. 19. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23: 762-770. 20. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118: 615-621. 21. Smith JA, Albenz J, Begley C, et al. The epidemiology of dry eye disease: Report of the epidemiology subcommittee of the international Dry Eye Workshop (2007). Ocul Surf 2007; 5: 93-107. 22. Sullivan BD, Crews LA, Sönmez В, et al. Clinical utility of objective tests for dry eye disease: Variability over time and implications for clinical trials and disease management. Cornea 2012; 31: 1000-1008. 23. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sei 2010; 51: 6125-6130. 24. Szakáts I, Sebestyén M, Németh J, et aI. A Szemfelszíni Betegség Kérdőív magyar változatának megbízhatósága és érvényessége. Szemészet 2014; 151: 167-171. 25. Szalai E, Berta A, Szekanecz Z, et al. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea 2012; 31: 867-871. 26. Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee. Invest Ophthalmol Vis Sei 2011; 52: 2006-2049. 27. Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: Determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sei 2006; 47: 4309-4315. 28. Versura R Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res 2010; 35: 553-564. □r. Szakáts Ildikó, 2400 Dunaújváros, Korányi S. u. 4-6. E-mail: szakatsildiko@gmail.com Congress Report Your conference coverage International and World Congresses ASCO ANNUAL MEETNG COLLfCTTVE WISDOM June 3-7,2016 Chicago, Inois The European Society of Contraception and Reproductive Health American Congress of Dermatology 2016 March Ш-ÜS. 20l<> Q Hachlnglon.lW. ^ American Society of Hematology l = December 5-8. 2015 Orlando Látogassa meg а еондгеадгержСеи portóiunkat!
